Topics
Glioblastoma | Treatment | Immunotherapy | Gamma-Delta T cells
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Gamma-Delta T cells
2026
Nabors LB, Lobbous M, Han X, Fiveash J, Di Stasi A, Rochlin K,
Oster R, Pillay T, Miller R, Chandrashekar DS, Ter Haak M, Ho W,
Lamb LS Jr.
Intracranial Injection of
Investigational Ex Vivo Expanded and Activated Gamma-Delta T Cells
Engineered With a Methylguanine-DNA Methyltransferase-Expressing
Lentivector in Patients With Primary Glioblastoma.
J
Clin Oncol. 2026 Jul 8:JCO2502463. doi:
10.1200/JCO-25-02463. PMID:
42418736. Trial
registration ID: NCT04165941˰
ˍ
Chao CC, Shen HE, Zhang BB, Chao TC, Wang CW, Wu CC.
Challenges
and Opportunities of γδ T Cell-Based Immunotherapy for
Glioblastoma.
Biomedicines.
2026 Aug 6;14(8):1770. doi:
10.3390/biomedicines14081770. PMID:
42652153. ˍ